91st European Atherosclerosis Meeting
In the light of recent clinical trial results, there was much for clinicians and researchers at EAS 2023 (21-24 May, Mannheim, Germany), to debate about the role of triglycerides as a marker of cardiovascular risk or a target for treatment, as well as the importance of reducing apoB-containing particles. In addition, there were updates on […]
Read More > 91st European Atherosclerosis Meeting